(Q35913766)

11 August 2017

1 reference

title

Pharmaceutical approaches to the treatment of obesity (English)

1 reference

11 August 2017

0 references

2

Stephen C Woods

1 reference

11 August 2017

Ronald J Jandacek

1

1 reference

11 August 2017

1 October 2004

1 reference

11 August 2017

1 reference

11 August 2017

9

1 reference

11 August 2017

20

1 reference

11 August 2017

874-880

1 reference

Therapeutic controversy: Obesity--a modern-day epidemic.

11 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

The Obesity Epidemic Is a Worldwide Phenomenon

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

The Epidemic of Obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

Does obesity contribute as much to morbidity as poverty or smoking?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

The effects of obesity, smoking, and drinking on medical problems and costs

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

Increases in Clinically Severe Obesity in the United States, 1986-2000

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

Weight-reducing effects of the plasma protein encoded by the obese gene

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

Identification and expression cloning of a leptin receptor, OB-R

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

1 reference

7 January 2021

Positional cloning of the mouse obese gene and its human homologue

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

Leptin regulation of neuroendocrine systems

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

CNS melanocortin system involvement in the regulation of food intake.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

The Central Melanocortin System and Energy Homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

The arcuate nucleus as a conduit for diverse signals relevant to energy homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

From lesions to leptin: hypothalamic control of food intake and body weight.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

Obesity wars: molecular progress confronts an expanding epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

Central nervous system control of food intake

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

Signals that regulate food intake and energy homeostasis.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

Future directions in weight control. Molecular and genetic discoveries pave the way.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

Medicinal strategies in the treatment of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

Strategies and potential molecular targets for obesity treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

Pharmacotherapy of obesity: targets and perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

Transgenic study of energy homeostasis equation: implications and confounding influences

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

Pharmacological therapy of obesity: past, present, and future

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

1 reference

7 January 2021

Gastrointestinal satiety signals I. An overview of gastrointestinal signals that influence food intake

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

Adiponectin acts in the brain to decrease body weight.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

Fat hormones pull their weight in the CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

Is the energy homeostasis system inherently biased toward weight gain?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

Regulation of lipolysis: natriuretic peptides and the development of cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

Absence of perilipin results in leanness and reverses obesity in Lepr(db/db) mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

Does brown adipose tissue (BAT) have a role in the physiology or treatment of human obesity?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

The biology of mitochondrial uncoupling proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

Faecal Fat Excretion, Diarrhea, and Subjective Complaints with Highly Dosed Oral Fat Intake

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

Clinical use of sibutramine

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

Gut hormone PYY(3-36) physiologically inhibits food intake

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

Inhibition of food intake in obese subjects by peptide YY3-36

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

Molecular biology of serotonin receptors structure and function at the molecular level

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

Valvular heart disease associated with fenfluramine-phentermine

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

Are mood disorders and obesity related? A review for the mental health professional.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

Treatment of affective disorder and obesity with topiramate.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

Topiramate and weight loss in patients with neurodevelopmental disabilities.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

An anorexic lipid mediator regulated by feeding.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

Food intake is inhibited by oral oleoylethanolamide

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

Endogenous cannabinoid system as a modulator of food intake

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

Ciliary neurotrophic factor activates leptin-like pathways and reduces body fat, without cachexia or rebound weight gain, even in leptin-resistant obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

Regulation of insulin secretion and blood glucose metabolism by adrenomedullin

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

Expression of the adrenomedullin binding protein, complement factor H, in the pancreas and its physiological impact on insulin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

Regulation of pancreatic physiology by adrenomedullin and its binding protein.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

Be fit or be sick: peroxisome proliferator-activated receptors are down the road

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

PPARs and the complex journey to obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

Differential influences of peroxisome proliferator-activated receptors gamma and -alpha on food intake and energy homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR-alpha).

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

Olestra formulation and the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

A 9-mo randomized clinical trial comparing fat-substituted and fat-reduced diets in healthy obese men: the Ole Study

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

UCP3: an uncoupling protein homologue expressed preferentially and abundantly in skeletal muscle and brown adipose tissue

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

Gut peptides in the treatment of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

Recent advances in protein tyrosine phosphatase 1B inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

Role of protein tyrosine phosphatase-1B in diabetes and obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

Drugs targeting functional bowel disorders: insights from animal studies

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

Alternative role for prolactin-releasing peptide in the regulation of food intake.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

The prolactin-releasing peptide receptor (GPR10) regulates body weight homeostasis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

Fat (fat) and tubby (tub): two autosomal recessive mutations causing obesity syndromes in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

Prominent neuronal-specific tub gene expression in cellular targets of tubby mice mutation.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903244-1

7 January 2021

10.1016/S1359-6446(04)03244-1

Identifiers

DOI

1 reference

11 August 2017

1 reference

PubMed ID

15475320